Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Also Read | Despite a 134% jump in last 1 year, Elara has a sell call on this defense stock HUL finalized its merger with GlaxoSmithKline Consumer Healthcare Limited (GSKCH) in 2020, after ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last ...

The stock of pharma major GlaxoSmithKline Pharmaceuticals (GSK Pharma) was up about 5.7 per cent to Rs 3,059, taking the gains since its results earlier this month to 11 per cent. It has been a major ...

The site at Ulverston currently belongs to GlaxoSmithKline (GSK), which is winding down its operation there ahead of closure in 2025. Staff manufacture antibiotics under the brand name Zinnat.

Drugs giant GlaxoSmithKline (GSK) is launching a development plan that is set to create up to 5,000 new jobs. The company is looking to extend its facility in Stevenage, Hertfordshire, where it ...